1. A. A clinical director shall ensure that:

   1. 1. A treatment plan is developed and implemented for the patient:

      1. a. According to the behavioral health specialized transitional facility’s policies and procedures;
      2. b. Based on the assessment conducted under R9-10-1306(C)(4) and on-going changes to the assessment of the patient’s behavioral health issues, mental disorders, and physical health conditions, as applicable; and

      3. c. Including:

         1. i. The physical health services, behavioral health services, and ancillary services to be provided to the patient until completion of the treatment plan;
         2. ii. The type, frequency, and duration of counseling or other treatment ordered for the patient;
         3. iii. The name of each individual who ordered medication, counseling, or other treatment for the patient;
         4. iv. The signature of the patient or the patient’s representative and dated signed, or documentation of the refusal to sign;
         5. v. The date when the patient’s treatment plan will be reviewed;
         6. vi. If a discharge date has been determined, the treatment needed after discharge; and
         7. vii. The signature of the personnel member who developed the treatment plan and the date signed; and

   2. 2. A patient’s treatment plan is reviewed and updated:

      1. a. According to the review date specified in the treatment plan,
      2. b. When a treatment goal is accomplished or changes,
      3. c. When additional information that affects the patient’s assessment is identified, and
      4. d. When a patient has a significant change in condition or experiences an event that affects treatment.

2. B. A clinical director shall ensure that treatment is:

   1. 1. Offered to a patient according to the patient’s treatment plan;
   2. 2. Except for a patient obtaining treatment under A.R.S. § 36-512, only provided after obtaining informed consent to the treatment from the patient; and
   3. 3. Documented in the patient’s medical record as specified in R9-10-1312.
3. C. The clinical director shall ensure that restraint and seclusion are used, performed, and documented according to the behavioral health specialized transitional facility’s policies and procedures.

4. D. A clinical director shall ensure that:

   1. 1. A patient receives the annual examination required by A.R.S. § 36-3708, and
   2. 2. A report of the patient’s annual examination is prepared according to the behavioral health specialized transitional facility’s policies and procedures.

Historical Note

Emergency rule adopted effective November 29, 1991, pursuant to A.R.S. § 41-1026, valid for only 90 days (Supp. 91-4). Emergency rule adopted again effective February 28, 1992, pursuant to A.R.S. § 41-1026, valid for only 90 days (Supp. 92-1). Emergency rule adopted again effective May 28, 1992, pursuant to A.R.S. § 41-1026, valid for only 90 days (Supp. 92-2). Emergency rule adopted again effective August 27, 1992, pursuant to A.R.S. § 41-1026, valid for only 90 days (Supp. 92-3). Adopted with changes effective November 25, 1992 (Supp. 92-4). Section R9-10-1310 repealed effective November 1, 1998, under an exemption from the provisions of the Administrative Procedure Act pursuant to Laws 1998, Ch. 178, § 17; filed with the Office of the Secretary of State October 2, 1998 (Supp. 98-4). New Section made by exempt rulemaking at 19 A.A.R. 2015, effective October 1, 2013 (Supp. 13-2). Amended by exempt rulemaking at 20 A.A.R. 1409, pursuant to Laws 2013, Ch. 10, § 13; effective July 1, 2014 (Supp. 14-2). Amended by final expedited rulemaking at 24 A.A.R. 2764, effective September 11, 2018 (Supp. 18-3).